| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics, Inc. (VYGR) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.1K | $2.01M | - | |
| COO | 199.7K | $828.9K | - | |
| Other | 183.9K | $763.2K | - | |
| CFO | 151.4K | $628.4K | - | |
| Other | 145.7K | $604.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2020 | Ottmer Matthew P. | Chief Operating Officer | Sell | 3,724 | $13.36 | $49,752.64 | -12.4% | |
| Jan 21, 2020 | Turenne Andre | President &CEO | Sell | 10,705 | $13.36 | $143,018.80 | -11.1% | |
| Sep 12, 2018 | Pierce Glenn | Director | Buy | 5,000 | $18.44 | $92,200.00 | New | |
| Sep 10, 2018 | Geraghty James A | Director | Buy | 3,000 | $19.39 | $58,170.00 | +4.1% | |
| Aug 17, 2018 | Geraghty James A | Director | Buy | 3,000 | $18.31 | $54,930.00 | +4.3% | |
| Apr 10, 2018 | Ravina Bernard | Chief Medical Officer | Sell | 2,451 | $18.38 | $45,049.38 | -100% | |
| Mar 23, 2018 | Henderson Jane72 | Sr. V.p. &CFO, Corp. Dev. | Sale+OE | 31,100 | $20.87 | $649,117.00 | -100% | |
| Mar 19, 2018 | Henderson Jane72 | CFO &SVP, Corp. Dev. | Sale+OE | 17,316 | $22.11 | $382,808.40 | -100% | |
| Mar 12, 2018 | Ravina Bernard | Chief Medical Officer | Sell | 2,451 | $25.16 | $61,667.16 | -50.0% | |
| Feb 27, 2018 | Sah Dinah Ph.d. | Chief Scientific Officer | Sale+OE | 15,623 | $30.00 | $468,690.00 | -10.1% |